Imid

Imid company information, Employees & Contact Information

Explore related pages

Related company profiles:

imID delivers secure, reliable, and compliant electronic identity solutions for individuals, businesses, and government entities. We strive to meet the highest EU standards for security, integrity, and confidentiality in electronic transactions, ensuring that every digital interaction—whether for signing documents, verifying identities, or securing communications—is protected with robust cryptographic and operational safeguards. Our services include; Qualified Electronic Signatures: Legally binding electronic signatures that ensure document integrity and authenticity. Electronic Seals: Secure seals for documents that verify the origin and integrity of electronic communications. Time Stamping Services: Reliable time stamps that provide proof of the existence of a document at a specific time.

Company Details

Employees
33
Address
Yerevan, Am
Industry
Technology, Information And Internet
Keywords
include;.
HQ
Yerevan
Looking for a particular Imid employee's phone or email?

Imid Questions

News

imID to roll out digital ID app for streamlined IDV in Armenia - Biometric Update

imID to roll out digital ID app for streamlined IDV in Armenia Biometric Update

imID, Armenia’s Trust Service Provider Joins Digitec 2025 - Armenpress

imID, Armenia’s Trust Service Provider Joins Digitec 2025 Armenpress

imID Launches “MobileID eSIM” Solution in Armenia - Hetq.am

imID Launches “MobileID eSIM” Solution in Armenia Hetq.am

imID Launches “MobileID eSIM” Solution in Armenia - NEWS.am

imID Launches “MobileID eSIM” Solution in Armenia NEWS.am

imID and SK ID Solutions Partner to Launch imID Digital ID App in Armenia - Armenpress

imID and SK ID Solutions Partner to Launch imID Digital ID App in Armenia Armenpress

imID acquires Mobile ID system from Viva, opening a new era for Armenia’s digital identity - Բիզնես 24

imID acquires Mobile ID system from Viva, opening a new era for Armenia’s digital identity Բիզնես 24

Armenia’s bank-backed imID buys mobile ID system - Biometric Update

Armenia’s bank-backed imID buys mobile ID system Biometric Update

iTAG an optimized IMiD-induced degron for targeted protein degradation in human and murine cells - ScienceDirect.com

iTAG an optimized IMiD-induced degron for targeted protein degradation in human and murine cells ScienceDirect.com

Central Bank of Armenia hosts representatives of imID and SK ID Solutions - Armenpress

Central Bank of Armenia hosts representatives of imID and SK ID Solutions Armenpress

imID sets a new standard and level for digital identity in Armenia - Բիզնես 24

imID sets a new standard and level for digital identity in Armenia Բիզնես 24

Evidence-based mechanisms of synergy with IMiD agent-based combinations in multiple myeloma - ScienceDirect.com

Evidence-based mechanisms of synergy with IMiD agent-based combinations in multiple myeloma ScienceDirect.com

Digital identity, digital authentication, and secure transactions: the imID office is officially opened - Բիզնես 24

Digital identity, digital authentication, and secure transactions: the imID office is officially opened Բիզնես 24

IMiD resistance in multiple myeloma: current understanding of the underpinning biology and clinical impact - ScienceDirect.com

IMiD resistance in multiple myeloma: current understanding of the underpinning biology and clinical impact ScienceDirect.com

Signing-up in AEB Mobile is now available via imID - Tert.am

Signing-up in AEB Mobile is now available via imID Tert.am

An IMiD-inducible degron provides reversible regulation for chimeric antigen receptor expression and activity - ScienceDirect.com

An IMiD-inducible degron provides reversible regulation for chimeric antigen receptor expression and activity ScienceDirect.com

Discovery of KT-413, a Targeted Protein Degrader of IRAK4 and IMiD Substrates Targeting MYD88 Mutant Diffuse Large B-Cell Lymphoma | Journal of Medicinal Chemistry - ACS Publications

Discovery of KT-413, a Targeted Protein Degrader of IRAK4 and IMiD Substrates Targeting MYD88 Mutant Diffuse Large B-Cell Lymphoma | Journal of Medicinal Chemistry ACS Publications

The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myeloma - ScienceDirect.com

The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myeloma ScienceDirect.com

Long-term outcomes of IMiD-based trials in patients with immunoglobulin light-chain amyloidosis: a pooled analysis - Nature

Long-term outcomes of IMiD-based trials in patients with immunoglobulin light-chain amyloidosis: a pooled analysis Nature

IMiD/CELMoD-induced growth suppression of adult T-cell leukemia/lymphoma cells via cereblon through downregulation of target proteins and their downstream effectors - Frontiers

IMiD/CELMoD-induced growth suppression of adult T-cell leukemia/lymphoma cells via cereblon through downregulation of target proteins and their downstream effectors Frontiers

Universal Display Corporation Presents and Announces Recipients of the 2025 UDC Innovative Research and Pioneering Technology Awards at IMID Korea - Business Wire

Universal Display Corporation Presents and Announces Recipients of the 2025 UDC Innovative Research and Pioneering Technology Awards at IMID Korea Business Wire

Structural bases of IMiD selectivity that emerges by 5-hydroxythalidomide - Nature

Structural bases of IMiD selectivity that emerges by 5-hydroxythalidomide Nature

An IMiD-induced SALL4 degron system for selective degradation of target proteins - Nature

An IMiD-induced SALL4 degron system for selective degradation of target proteins Nature

Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango? - Frontiers

Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango? Frontiers

Peptidic degron for IMiD-induced degradation of heterologous proteins - PNAS

Peptidic degron for IMiD-induced degradation of heterologous proteins PNAS

[IMID 2025] LG Display Showcases AI-Optimized Display Technologies and Future Vision - LG Display Newsroom

[IMID 2025] LG Display Showcases AI-Optimized Display Technologies and Future Vision LG Display Newsroom

Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019 - The Lancet

Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019 The Lancet

[IMID 2024] LG Display’s Visionary Journey Towards an Innovative Future - LG Display Newsroom

[IMID 2024] LG Display’s Visionary Journey Towards an Innovative Future LG Display Newsroom

LG Display presents vision for future of displays leading AI innovation at IMID 2025 - LG Display Newsroom

LG Display presents vision for future of displays leading AI innovation at IMID 2025 LG Display Newsroom

LG Display Makes its Mark on IMID 2021 - LG Display Newsroom

LG Display Makes its Mark on IMID 2021 LG Display Newsroom

[IMID 2023] Catch a Glimpse of the Future at IMID 2023 with LG Display - LG Display Newsroom

[IMID 2023] Catch a Glimpse of the Future at IMID 2023 with LG Display LG Display Newsroom

pSILAC mass spectrometry reveals ZFP91 as IMiD-dependent substrate of the CRL4 - Nature

pSILAC mass spectrometry reveals ZFP91 as IMiD-dependent substrate of the CRL4 Nature

Cancer risk in immune-mediated inflammatory diseases (IMID) - Molecular Cancer

Cancer risk in immune-mediated inflammatory diseases (IMID) Molecular Cancer

In-Situ Raman Study of the Intercalation of Bis(trifluoromethylsulfonyl)imid Ions into Graphite inside a Dual-Ion Cell - ScienceDirect.com

In-Situ Raman Study of the Intercalation of Bis(trifluoromethylsulfonyl)imid Ions into Graphite inside a Dual-Ion Cell ScienceDirect.com

IMID Access 4.0, a new generation of biometric visual identification solutions - Security Info Watch

IMID Access 4.0, a new generation of biometric visual identification solutions Security Info Watch

NIHR IMID BioResource recruits its 10,000th volunteer in major milestone - Cambridge Network

NIHR IMID BioResource recruits its 10,000th volunteer in major milestone Cambridge Network

UK collaboration sees IMID BioResource pass major recruitment milestone - Manchester University NHS Foundation Trust

UK collaboration sees IMID BioResource pass major recruitment milestone Manchester University NHS Foundation Trust

Manchester lupus patient first recruit to NIHR IMID BioResource - Manchester University NHS Foundation Trust

Manchester lupus patient first recruit to NIHR IMID BioResource Manchester University NHS Foundation Trust

The evolution of thalidomide and its IMiD derivatives as anticancer agents - Nature

The evolution of thalidomide and its IMiD derivatives as anticancer agents Nature

Motorists urged to update driver numbers or risk inability to renew car insurance - BreakingNews.ie

Motorists urged to update driver numbers or risk inability to renew car insurance BreakingNews.ie

Team subscribers will be able to contact the call center for identification using Mobile ID imID and save time - ARKA-Telecom

Team subscribers will be able to contact the call center for identification using Mobile ID imID and save time ARKA-Telecom

Armenian telecom operators announce the launch of eSIM Mobile ID solution - ARKA-Telecom

Armenian telecom operators announce the launch of eSIM Mobile ID solution ARKA-Telecom

Top Imid Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant